Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Medical tech firm Haemonetics merges plasma, blood segments into Apheresis

Summary by stocktitan.net
Recast revenue and 2027 guidance align with Haemonetics' new Apheresis and MedSurg segments, starting Q1 FY 2027 reporting; details posted online.
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

stocktitan.netstocktitan.net

Medical tech firm Haemonetics merges plasma, blood segments into Apheresis

Recast revenue and 2027 guidance align with Haemonetics' new Apheresis and MedSurg segments, starting Q1 FY 2027 reporting; details posted online.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

stocktitan.net broke the news on Friday, June 5, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

Braintree, Massachusetts icon

Braintree, Massachusetts

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal